Export
Tablet coating material exported from Tahliwal
The same 22 grades we supply across India ship to solid dosage manufacturers outside it. One works, one set of formulations, and documentation matched to the market the consignment is going to.
What ships
Ready-mix film, enteric, moisture barrier, seal, sugar, metallic and pearl, sustained release, taste mask and dissolution grades, across 10 coating systems. They are finished formulations, dispersed in water or solvent at your end and sprayed straight into the pan, so nothing is weighed or blended after they arrive.
Who buys them
Solid dosage manufacturers and contract manufacturers making tablets and capsules, in pharmaceutical, nutraceutical, ayurvedic and herbal manufacture. Export oriented units carry a higher documentation bar than domestic supply, and that is set by the importing market rather than by us.
Shade matching
Send a retained sample of the tablet you are matching and we will develop the shade against it. This is the part that most often decides whether a coating supplier is worth changing to, and it does not work from a colour code alone.
Exported from
- Works
- Plot No. 30, Industrial Area Tahliwal
- District
- Tehsil Haroli, Distt. Una 174507
- State
- Himachal Pradesh, India
- Compliance
- WHO-GMP Compliance Unit
- Licence
- NNZ/23/238
- DMF
- U.S.-DMF applied
- Brand
- Rglax Coat
Industries served
- PharmaceuticalDrugs and Cosmetics Act
- NutraceuticalFSSAI
- Ayurvedic and herbalSchedule T
- Formulation developmentR&D and FDD teams
- Contract manufacturingToll and third party
How an export order runs
Four steps, in order
Nothing here is unusual. It is written down so you know what to expect and what we will ask you for.
01 · Enquiry
Tell us the tablet, the target and the destination
Send the active, the dosage form, the release profile you are working to, your coater and batch size, and the country the material is going to. The destination matters, because it sets what documentation has to travel with the consignment.
02 · Sample
A trial quantity before a commercial order
We send a trial quantity with the process parameters the grade was developed on, so your team can run it on your own pan before anyone commits to a volume. Shade is matched against a sample you send us.
03 · Documentation
The paperwork your importing authority asks for
What is required varies by destination, so we confirm the list against your regulatory affairs team rather than assuming it. Tell us the market and we will tell you plainly what we can supply and what we cannot.
04 · Despatch
Packed and shipped from Tahliwal
Consignments leave our works in Una district, Himachal Pradesh. Packing, quantity and shipping terms are agreed per order.
What we export
The same grades we supply across India, coated on our own pan.
Metallic gold film coat
Metallic blue DB3012
Aqueous colour film coat
Extra white film coat
Pearl and metallic finish
High gloss metallic finish
Regions
Grouped by the framework you work under
Markets are gathered by regulatory framework rather than listed country by country, because the framework is what actually changes what we have to supply.
| Region | Markets | Regulators | Pharmacopoeia |
|---|---|---|---|
| Africa | Nigeria, Kenya, Ghana, Tanzania, Uganda, Ethiopia, South Africa | NAFDAC, Nigeria · PPB, Kenya · FDA, Ghana · TMDA, Tanzania · SAHPRA, South Africa | British Pharmacopoeia and USP are both in common use, with WHO guidance underneath. |
| Middle East and GCC | Saudi Arabia, United Arab Emirates, Oman, Kuwait, Qatar, Bahrain, Jordan, Egypt, Iraq | SFDA, Saudi Arabia · MOHAP, United Arab Emirates · GCC centralised registration · EDA, Egypt | European Pharmacopoeia and USP, with the Gulf states generally following EU expectations. |
| Southeast Asia | Indonesia, Philippines, Vietnam, Malaysia, Thailand, Myanmar, Cambodia | BPOM, Indonesia · FDA, Philippines · DAV, Vietnam · NPRA, Malaysia · Thai FDA | USP and BP predominate, with national pharmacopoeias in Indonesia and Vietnam. |
| South Asia | Bangladesh, Sri Lanka, Nepal, Bhutan, Maldives | DGDA, Bangladesh · NMRA, Sri Lanka · DDA, Nepal | British Pharmacopoeia predominantly, with USP in use. |
| CIS and Central Asia | Uzbekistan, Kazakhstan, Azerbaijan, Georgia, Armenia, Belarus, Kyrgyzstan | EAEU GMP framework · National agencies in Uzbekistan and Kazakhstan | State pharmacopoeias alongside European Pharmacopoeia references. |
| Latin America | Brazil, Mexico, Colombia, Peru, Chile, Argentina | ANVISA, Brazil · COFEPRIS, Mexico · INVIMA, Colombia · DIGEMID, Peru | USP predominantly, with the Brazilian Pharmacopoeia applying in Brazil. |
| Europe and the UK | European Union member states, United Kingdom, Switzerland, Turkey | EDQM · EMA and national competent authorities · MHRA, United Kingdom | European Pharmacopoeia, with the British Pharmacopoeia in the United Kingdom. |
| North America | United States, Canada | US FDA · Health Canada | USP-NF, with excipient monographs in the National Formulary. |
| Australia and New Zealand | Australia, New Zealand | TGA, Australia · Medsafe, New Zealand | British Pharmacopoeia and European Pharmacopoeia, with USP accepted. |
Regulatory requirements differ by destination, and we would rather confirm what a given market needs with you than publish a list that turns out to be wrong for your case. Send us the country and the product and we will answer specifically. Send an export enquiry.